184 related articles for article (PubMed ID: 31965687)
21. Livedoid vasculopathy: review of pathogenesis, clinical presentation, diagnostic workup, and treatment.
Haunson GT; Judy DW; Prall NC; Miller RA
Cutis; 2012 Dec; 90(6):302-6. PubMed ID: 23409480
[TBL] [Abstract][Full Text] [Related]
22. Clinical analysis of skin lesions in livedoid vasculopathy: a study of 46 Chinese patients.
Zhao C; Jing K; Feng S
Int J Dermatol; 2023 Feb; 62(2):212-216. PubMed ID: 36411590
[TBL] [Abstract][Full Text] [Related]
23. Livedoid vasculopathy associated with sickle cell trait: significant improvement on aspirin treatment.
El Khoury J; Taher A; Kurban M; Kibbi AG; Abbas O
Int Wound J; 2012 Jun; 9(3):344-7. PubMed ID: 22044499
[TBL] [Abstract][Full Text] [Related]
24. Excellent Long-term Clinical Response to Rivaroxaban in Livedoid Vasculopathy: A Retrospective Study.
Morgado-Carrasco D; Ibaceta J; Iranzo P; Bosch-Amate X; Mascaró-Galy JM
Actas Dermosifiliogr; 2023 Feb; 114(2):183-185. PubMed ID: 36115384
[No Abstract] [Full Text] [Related]
25. Rivaroxaban prevents painful cutaneous infarctions in livedoid vasculopathy.
Kerk N; Drabik A; Luger TA; Schneider SW; Goerge T
Br J Dermatol; 2013 Apr; 168(4):898-9. PubMed ID: 23106384
[No Abstract] [Full Text] [Related]
26. Livedoid vasculopathy secondary to high levels of lipoprotein(a).
Vasconcelos R; Criado PR; Belda W
Br J Dermatol; 2011 May; 164(5):1111-3. PubMed ID: 21219292
[No Abstract] [Full Text] [Related]
27. Prevention of recurrent ulceration of livedoid vasculopathy with long-term apixaban monotherapy.
Osada SI; Ishikawa N; Hasunuma N; Manabe M
J Dermatol; 2019 Apr; 46(4):e142-e143. PubMed ID: 30156315
[No Abstract] [Full Text] [Related]
28. Livedoid vasculopathy and peripheral neuropathy: A retrospective cohort study of 55 Chinese patients and literature review.
Gao Y; Jin H
Int Wound J; 2023 May; 20(5):1498-1505. PubMed ID: 36333819
[TBL] [Abstract][Full Text] [Related]
29. Livedoid vasculopathy - a thrombotic disease.
Kerk N; Goerge T
Vasa; 2013 Sep; 42(5):317-22. PubMed ID: 23989066
[TBL] [Abstract][Full Text] [Related]
30. Livedoid vasculopathy with underlying subcutaneous necrotizing venulitis in an asymptomatic hepatitis B virus carrier: is livedoid vasculopathy a true nonvasculitic disorder?
Ishibashi M; Miyamoto J; Nagasaka T; Chen KR
Am J Dermatopathol; 2009 May; 31(3):293-6. PubMed ID: 19384073
[TBL] [Abstract][Full Text] [Related]
31. Livedoid vasculopathy in Koreans: clinical features and response to rivaroxaban treatment.
Lee JS; Cho S
J Eur Acad Dermatol Venereol; 2020 Apr; 34(4):e176-e178. PubMed ID: 31793049
[No Abstract] [Full Text] [Related]
32. Livedoid vasculopathy and its association with factor V Leiden mutation.
Yong AA; Tan AW; Giam YC; Tang MB
Singapore Med J; 2012 Dec; 53(12):e258-60. PubMed ID: 23268168
[TBL] [Abstract][Full Text] [Related]
33. Livedoid vasculopathy and recurrent thrombosis in a patient with lupus: seronegative antiphospholipid syndrome?
Sopeña B; Pérez-Rodríguez MT; Rivera A; Ortiz-Rey JA; Lamas J; Freire-Dapena MC
Lupus; 2010 Oct; 19(11):1340-3. PubMed ID: 20659971
[TBL] [Abstract][Full Text] [Related]
34. Treatment of livedoid vasculopathy with alprostadil (PGE-1): case report and review of published literature.
Mofarrah R; Aberer W; Aberer E
J Eur Acad Dermatol Venereol; 2013 Feb; 27(2):e252-4. PubMed ID: 22364635
[No Abstract] [Full Text] [Related]
35. Real-world data on pain management and effectiveness of anti-tumour necrosis factor agents in refractory livedoid vasculopathy.
Gao Y; Jin H
J Eur Acad Dermatol Venereol; 2022 Jan; 36(1):e46-e48. PubMed ID: 34416092
[No Abstract] [Full Text] [Related]
36. Unilateral livedoid vasculopathy associated with involutional phase of cutaneous infantile hemangioma: the connection to coagulation disorders.
Criado PR; Alavi A; Halpern I; Sotto MN; Kirsner RS
Int J Low Extrem Wounds; 2013 Dec; 12(4):306-9. PubMed ID: 24043683
[TBL] [Abstract][Full Text] [Related]
37. Livedoid vasculopathy as a marker of systemic disease: report of two cases.
Lima RS; Maquiné GÁ; Talhari C; Encarnação IC; Schettini AP; Santos M
An Bras Dermatol; 2014; 89(5):822-4. PubMed ID: 25184928
[TBL] [Abstract][Full Text] [Related]
38. New hope for patients with livedoid vasculopathy.
Kirsner RS
Lancet Haematol; 2016 Feb; 3(2):e56-7. PubMed ID: 26853641
[No Abstract] [Full Text] [Related]
39. Homeopathic treatment in resistant livedoid vasculopathy: case report.
Waisse-Priven S; Jurj G; Lima Thomaz LC; Tierno SA; Filho WL; Sos AB
Homeopathy; 2009 Jul; 98(3):165-8. PubMed ID: 19647211
[TBL] [Abstract][Full Text] [Related]
40. [Livedoid vasculopathy secondary to coeliac disease].
Henry J; Brault F; Brouillard C; Baudin M; Gervaise A; Pouaha J; Cuny JF; Valois A
Ann Dermatol Venereol; 2017 May; 144(5):374-377. PubMed ID: 28283193
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
